Literature DB >> 8910361

Crystal structure of p38 mitogen-activated protein kinase.

K P Wilson1, M J Fitzgibbon, P R Caron, J P Griffith, W Chen, P G McCaffrey, S P Chambers, M S Su.   

Abstract

p38 mitogen-activated protein kinase is activated by environmental stress and cytokines and plays a role in transcriptional regulation and inflammatory responses. The crystal structure of the apo, unphosphorylated form of p38 kinase has been solved at 2.3 A resolution. The fold and topology of p38 is similar to ERK2 (Zhang, F., Strand, A., Robbins, D., Cobb, M. H., and Goldsmith, E. J. (1994) Nature 367, 704-711). The relative orientation of the two domains of p38 kinase is different from that observed in the active form of cAMP-dependent protein kinase. The twist results in a misalignment of the active site of p38, suggesting that the orientation of the domains would have to change before catalysis could proceed. The residues that are phosphorylated upon activation of p38 are located on a surface loop that occupies the peptide binding channel. Occlusion of the active site by the loop, and misalignment of catalytic residues, may account for the low enzymatic activity of unphosphorylated p38 kinase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910361     DOI: 10.1074/jbc.271.44.27696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Two-dimensional crystal structures of protein kinase C-delta, its regulatory domain, and the enzyme complexed with myelin basic protein.

Authors:  Alexander S Solodukhin; Heather L Caldwell; Julianne J Sando; Robert H Kretsinger
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

2.  Phosphorylation-dependent changes in structure and dynamics in ERK2 detected by SDSL and EPR.

Authors:  Andrew N Hoofnagle; James W Stoner; Thomas Lee; Sandra S Eaton; Natalie G Ahn
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

3.  Modified AutoDock for accurate docking of protein kinase inhibitors.

Authors:  Oleksandr V Buzko; Anthony C Bishop; Kevan M Shokat
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

Review 4.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 5.  MAPK machinery in plants: recognition and response to different stresses through multiple signal transduction pathways.

Authors:  Gohar Taj; Payal Agarwal; Murray Grant; Anil Kumar
Journal:  Plant Signal Behav       Date:  2010-11-01

6.  Ischaemic/reperfusion injury: Role of infliximab.

Authors:  Atul Bagul
Journal:  World J Transplant       Date:  2012-06-24

7.  A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580.

Authors:  Sarawut Kumphune; Rekha Bassi; Sebastien Jacquet; Pierre Sicard; James E Clark; Sharwari Verma; Metin Avkiran; Stephen J O'Keefe; Michael S Marber
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

8.  Combination of two activating mutations in one HOG1 gene forms hyperactive enzymes that induce growth arrest.

Authors:  Gilad Yaakov; Michal Bell; Stefan Hohmann; David Engelberg
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.

Authors:  T Fox; J T Coll; X Xie; P J Ford; U A Germann; M D Porter; S Pazhanisamy; M A Fleming; V Galullo; M S Su; K P Wilson
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

10.  Structural and functional analysis of phosphorylation-specific binders of the kinase ERK from designed ankyrin repeat protein libraries.

Authors:  Lutz Kummer; Petra Parizek; Peter Rube; Bastian Millgramm; Anke Prinz; Peer R E Mittl; Melanie Kaufholz; Bastian Zimmermann; Friedrich W Herberg; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.